| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.00099 | 1 |